The Australian Nuclear Science and Technology Organisation (ANSTO) is importing technetium-99m (Tc-99m) generators from the United States to supply Australian hospitals, clinics and pharmaceutical suppliers.
A spokesperson from ANSTO has provided a statement
Experiments at ANSTO have helped increase an understanding some of the viscoelastic properties of polymers.
Carbon nanotubes have been incorporated into a blend of deuterated biopolymers, allowing for electrical conductivity of the polymer film. These polymers have potential implications as scaffolds supporting regrowth of damaged tissues and electrical conductivity can promote the re-growth of nerve cells on similar materials.
ANSTO has have contributed to research involving doping transition metals in a polymorph of bismuth oxide in a search for more structural stability.
Technetium-99m (Tc-99m) is used in hospitals around the world to diagnose a variety of heart, lung and musculoskeletal conditions, as well as cancers. It is the most common nuclear medicine, with global demand estimated to be up to 40 million doses a year, produced by experts with a small network of 11* nuclear reactors worldwide.
An ANSTO health researcher has received a number of awards for her contribution to the development of a new hybrid technique that enhances the effectiveness of an advanced form of radiation therapy for cancer.
The Australian Centre for Neutron Scattering & National Deuteration Facility Advisory Committee, which provides strategic advice, met last week at ANSTO under the guidance of Prof Brendan Kennedy (University of Sydney).
By carrying out micro-mechanical testing on single crystals of nickel, ANSTO materials researchers were able to derive the bulk properties of a polycrystalline material in a way that is useful for engineering.